Maternal hyperandrogenism beginning from early pregnancy and progressing until delivery does not produce virilization of a female newborn.

Second Department of Medicine, Semmelweis University, Budapest, Hungary.
Gynecological Endocrinology (Impact Factor: 1.3). 11/2007; 23(10):581-3. DOI:10.1080/09513590701553571
Source: PubMed

ABSTRACT A 33-year-old primagravida with a history of polycystic ovary syndrome was referred because of symptoms of moderate hyperandrogenism. Serum hormone levels, measured regularly from the 7th week of pregnancy until delivery, showed very high increases of testosterone, androstenedione and estradiol. Ultrasound showed no evidence of adrenal or ovarian masses. She delivered a female newborn with normal female external genitalia. Umbilical cord hormone levels were normal, except for a modest increase of serum testosterone. After delivery the androgen levels of the mother returned to normal and the symptoms of hyperandrogenism were also slightly improved.

0 0
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Transdermal testosterone gels are used in the treatment of hypoandrogenism of males. Virilization due to exposure to testosterone gels has been reported in children resulting in a US Food and Drug Administration (FDA) warning about secondary exposure to these products. At present, we are unaware of prenatal virilization associated with unintentional testosterone gel exposure. We report prenatal virilization in a female infant due to secondary maternal exposure to the father's testosterone gel. We also describe postnatal virilization of the child's twin sister.
    International Journal of Pediatric Endocrinology 01/2010; 2010:867471.